Scottish Brain Sciences has been created by a team of scientific experts with over 25 years’ experience of delivering world-leading neuroscience research. Backed by investors, pharmaceutical partners and leading universities, we are committed to delivering a step change in the early detection and treatment of brain conditions such as Alzheimer’s disease.

Our mission

We deliver clinical trials of new tests and medicines that aim to detect brain disease early and treat it before it progresses to dementia. We provide a full-service model for clinical research, with dedicated brain health research centres, an in-house laboratory and imaging services.

Together with our participants, we are building one of the world’s largest biobanks of genetic, blood and imaging data in neurodegenerative disease.

Our goal is to speed progress in the search for better Alzheimer’s diagnostics and treatments so that everyone can enjoy better brain health for life.

Our team

Founded in 2022 by Professor Craig Ritchie, the company is led by a team of neuroscience researchers who have published academic papers in leading peer-reviewed journals including the Lancet, the British Medical Journal and the Journal of the Prevention of Alzheimer’s Disease.